Positive Phase 3 HERIZON-GEA-01 results for Ziihera® (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal ...
CoreWeave grows amid $18B debt, negative FCF, and timing gaps between infrastructure and cash generation. Check out why CRWV ...
Positive Phase 3 HERIZON-GEA-01 results for Ziihera (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal adenocarcinoma (GEA) presented at ASCO GI Up to $440.0 million in milestone ...
A year since the Lighthouse Mission moved to its new building in Old Town Bellingham and shifted its model, staff are reporting promising results.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback